Загрузка...

Intravenous Thrombolysis in Expanded Time Window (3-4.5 hours) in General Practice with Concurrent Availability of Endovascular Treatment

INTRODUCTION: A randomized double-blind trial (ECASS III) demonstrated that intravenous (IV) recombinant tissue plasminogen activator (rt-PA) administered between 3 and 4.5 hrs after the onset of symptoms significantly improved clinical outcomes in patients with acute ischemic stroke. In May 2009, t...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Tekle, Wondwossen G, Chaudhry, Saqib A, Fatima, Zara, Ahmed, Maryam, Khalil, Shujaat, Hassan, Ameer E, Rodriguez, Gustavo J, Suri, Fareed K, Qureshi, Adnan I
Формат: Artigo
Язык:Inglês
Опубликовано: Zeenat Qureshi Stroke Research Center 2012
Предметы:
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3379904/
https://ncbi.nlm.nih.gov/pubmed/22737262
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!